Enantioselective Synthesis of Allylboronates and Allylic Alcohols by Copper-Catalyzed 1,6-Boration

Chiral secondary allylboronates are obtained in high enantioselectivities and 1,6:1,4 ratios by the copper‐catalyzed 1,6‐boration of electron‐deficient dienes with bis(pinacolato)diboron (B2(pin)2). The reactions proceed efficiently using catalyst loadings as low as 0.0049 mol %. The allylboronates...

Full description

Saved in:
Bibliographic Details
Published inAngewandte Chemie International Edition Vol. 53; no. 16; pp. 4186 - 4190
Main Authors Luo, Yunfei, Roy, Iain D., Madec, Amaël G. E., Lam, Hon Wai
Format Journal Article
LanguageEnglish
Published Weinheim WILEY-VCH Verlag 14.04.2014
WILEY‐VCH Verlag
Wiley
Wiley Subscription Services, Inc
EditionInternational ed. in English
Subjects
Online AccessGet full text
ISSN1433-7851
1521-3773
1521-3773
DOI10.1002/anie.201310380

Cover

More Information
Summary:Chiral secondary allylboronates are obtained in high enantioselectivities and 1,6:1,4 ratios by the copper‐catalyzed 1,6‐boration of electron‐deficient dienes with bis(pinacolato)diboron (B2(pin)2). The reactions proceed efficiently using catalyst loadings as low as 0.0049 mol %. The allylboronates may be oxidized to the allylic alcohols, and can be used in stereoselective aldehyde allylborations. This process was applied to a concise synthesis of atorvastatin, in which the key 1,6‐boration was performed using only a 0.02 mol % catalyst loading. 1,6‐Borations of electron‐deficient dienes with bis(pinacolato)diboron using copper catalyst loadings as low as 0.0049 mol % provided chiral allylboronates that, after oxidation, result in allylic alcohols in high enantioselectivities and 1,6:1,4 ratios. The allylboronates can also be used in stereoselective allylations of aldehydes. This process was applied to a concise synthesis of atorvastatin.
Bibliography:We thank the ERC (Starting Grant No. 258580), the EPSRC (Leadership Fellowship to H.W.L.), Pfizer, AstraZeneca, and the University of Edinburgh for support. We thank Xiaoming Yang of Shanghai Chiral Chemistry Co., Ltd. for providing starting materials and NMR data for atorvastatin (13). We are grateful to Dr. Gary S. Nichol (University of Edinburgh) for X-ray crystallography, and the EPSRC National Mass Spectrometry Facility for high-resolution mass spectra. We thank Dr. Ai-Lan Lee at Heriot-Watt University for the use of a polarimeter.
ark:/67375/WNG-4FKQRS7J-9
ArticleID:ANIE201310380
EPSRC - No. Pfizer; No. AstraZeneca; No. University of Edinburgh
ERC - No. 258580
istex:4461B2776AD0825ECF7DA6CF81C1960AFBB9E10C
13
We thank the ERC (Starting Grant No. 258580), the EPSRC (Leadership Fellowship to H.W.L.), Pfizer, AstraZeneca, and the University of Edinburgh for support. We thank Xiaoming Yang of Shanghai Chiral Chemistry Co., Ltd. for providing starting materials and NMR data for atorvastatin
We are grateful to Dr. Gary S. Nichol (University of Edinburgh) for X‐ray crystallography, and the EPSRC National Mass Spectrometry Facility for high‐resolution mass spectra. We thank Dr. Ai‐Lan Lee at Heriot‐Watt University for the use of a polarimeter.
researchfish
UKRI
European Research Council (ERC)
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1433-7851
1521-3773
1521-3773
DOI:10.1002/anie.201310380